Reduced viability, migration, invasion, and stemness in hepatocellular cancer cells, reduced E2F-dependent transcription of cell cycle regulatory genes by decreasing AKT expression via KDM6B. The gene discussed is AKT1; the disease is hepatocellular carcinoma.